Literature DB >> 30706692

Histopathologic variables differentially affect melanoma survival by age at diagnosis.

Kriti Mishra1, Raymond L Barnhill2, Lisa E Paddock3, Judith Ann Fine, Marianne Berwick1.   

Abstract

We evaluated clinical, phenotypic, behavioral, and histopathologic variables in relationship to melanoma-specific survival by age at diagnosis among 650 population-based melanoma patients in Connecticut, with 20 years of follow-up. Only one variable, skin awareness, was significantly associated with melanoma mortality in both groups. The variables that differed between the age-groups were anatomic site, Breslow thickness, histologic subtype, mitoses, tumor-infiltrating lymphocytes (TILs), and solar elastosis. Head and neck melanoma, Breslow thickness, nodular melanoma, and solar elastosis were all significantly more likely to be associated with mortality among the older subjects; among the younger subjects, the presence of mitoses was associated with an increased probability of dying and TILs were associated with a reduced risk of mortality.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  histopathology; melanoma; sex; skin awareness; survival

Mesh:

Year:  2019        PMID: 30706692     DOI: 10.1111/pcmr.12770

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  2 in total

1.  Ultraviolet light-induced collagen degradation inhibits melanoma invasion.

Authors:  Timothy Budden; Caroline Gaudy-Marqueste; Andrew Porter; Emily Kay; Shilpa Gurung; Charles H Earnshaw; Katharina Roeck; Sarah Craig; Víctor Traves; Jean Krutmann; Patricia Muller; Luisa Motta; Sara Zanivan; Angeliki Malliri; Simon J Furney; Eduardo Nagore; Amaya Virós
Journal:  Nat Commun       Date:  2021-05-12       Impact factor: 17.694

Review 2.  Digital interventions for promoting sun protection and skin self-examination behaviors: A systematic review.

Authors:  Zhaomeng Niu; Trishnee Bhurosy; Carolyn J Heckman
Journal:  Prev Med Rep       Date:  2022-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.